Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/4/2025

Evaluation of Pancytopenia with Hepatosplenomegaly

Initial Clinical Assessment

  • The American Society of Hematology recommends a complete blood count with peripheral smear examination, followed by abdominal imaging to characterize hepatosplenomegaly, and then bone marrow aspiration and biopsy with cytogenetic analysis to distinguish between primary bone marrow pathology versus peripheral sequestration 1, 2
  • A drug exposure history, including prescription medications, over-the-counter drugs, alcohol consumption, and environmental toxins, is crucial as these are common reversible causes of pancytopenia with hepatosplenomegaly 3, 4
  • Infectious risk factors, particularly HIV, hepatitis C, and other chronic infections, should be assessed as they can cause both cytopenias and organomegaly 3, 4
  • Constitutional symptoms, including fever, weight loss, and night sweats, suggest lymphoproliferative disorders, infections, or hemophagocytic syndromes 3, 5
  • A family history of thrombocytopenia, bleeding disorders, or early-onset organomegaly can help identify inherited conditions 3, 1

Essential Laboratory Evaluation

  • A complete blood count with manual differential is necessary to confirm true pancytopenia and exclude pseudothrombocytopenia from EDTA-dependent platelet clumping 3, 6, 2
  • Peripheral blood smear examination by a qualified hematologist or pathologist is paramount to identify schistocytes, giant platelets, dysplastic features, or abnormal cells 3, 6
  • Reticulocyte count helps distinguish decreased production from increased destruction 3, 2
  • Liver function tests, including AST, ALT, bilirubin, and alkaline phosphatase, should be performed 1, 2
  • Vitamin B12 and folate levels must be checked early, as severe B12 deficiency can mimic hematologic malignancy with pancytopenia, lymphadenopathy, and fever 2

Imaging Studies

  • Abdominal ultrasound with Doppler is the initial imaging modality to confirm hepatosplenomegaly, assess liver and spleen morphology, identify focal lesions, and evaluate portal blood flow 1
  • CT or MRI of the abdomen provides a more detailed assessment when ultrasound is inadequate or when lymphadenopathy or infiltrative disease is suspected 1

Bone Marrow Examination

  • Bone marrow aspiration and biopsy with cytogenetic analysis are mandatory when the combination of pancytopenia and hepatosplenomegaly is present 3, 6, 2
  • Both aspirate and biopsy must be performed simultaneously to assess cellularity, morphology, and architecture 3, 2
  • Flow cytometry helps identify lymphoproliferative disorders, particularly chronic lymphocytic leukemia 3
  • Cytogenetic testing is necessary to identify myelodysplastic syndrome and other clonal disorders 3, 2

Differential Diagnosis Priority

  • Lymphoproliferative disorders, including lymphoma and chronic lymphocytic leukemia, should be considered in the differential diagnosis of pancytopenia with hepatosplenomegaly 3, 9
  • Hemophagocytic lymphohistiocytosis (HLH) presents with fever, hepatosplenomegaly, pancytopenia, hypertriglyceridemia, hypofibrinogenemia, and high ferritin, and requires aggressive treatment 5
  • Acid sphingomyelinase deficiency (ASMD) should be considered in young adults with unexplained hepatosplenomegaly, normal liver function tests, and mixed dyslipidemia 1

Specialized Testing Based on Initial Findings

  • Genetic testing for the SMPD1 gene is necessary if acid sphingomyelinase deficiency is suspected 1
  • Chest X-ray or CT should be performed to evaluate for interstitial lung disease, which commonly accompanies ASMD 1
  • Pulmonary function testing is recommended in suspected storage disorders 1
  • Antinuclear antibodies (ANA) and anti-dsDNA should be checked if systemic lupus erythematosus is clinically suspected 2
  • Hepatic venous pressure gradient (HVPG) is the gold standard for diagnosing portal hypertension, but is invasive and limited to specialized centers 1
  • LSPS score (combining liver stiffness, spleen size, and platelet count) improves diagnostic accuracy for portal hypertension 1